Company Profile
LogicMark Stock Price, News & Analysis
- Ticker:
- LGMK
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, LogicMark is followed within the biotech universe for its exposure to catalyst-driven execution.
Stock performance
1.09 USD (+35.67%)
Close
Last updated: June 23, 2026 at 00:00
—
Market cap
Why the stock is moving
LGMK is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
LogicMark is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, LogicMark is followed within the biotech universe for its exposure to catalyst-driven execution.
Business Model Characteristics
LogicMark follows a catalyst-driven model where the market watches how the company turns development work into repeatable value creation.
Position Within the Biotechnology Landscape
Compared with more mature healthcare peers, LogicMark sits closer to the development side of the biotechnology landscape, where timing around data and approvals matters most.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of LogicMark (LGMK)?
LogicMark (LGMK) most recently closed at 1.09 USD, a +35.67% move versus the previous session.
What does LogicMark do?
LogicMark is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
On which exchange is LGMK stock listed?
LogicMark (LGMK) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, LogicMark is followed within the biotech universe for its exposure to catalyst-driven execution., Biotechnology.
What is LogicMark?
LogicMark is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.
Which conditions is LogicMark targeting with LogicMark?
LogicMark is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
What is Investors?
Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.